Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Merck & Co
(NY:
MRK
)
125.89
+0.45 (+0.36%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Merck & Co
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
69
70
Next >
How Long Can This Top Stock Continue Defying the Bear Market?
November 17, 2022
It could only be the beginning for this pharma giant.
Via
The Motley Fool
4 Reasons to Buy This Hybrid of a Growth and Income Stock
November 17, 2022
This drugmaker's dividend yield is currently well above the average yield among S&P 500 stocks.
Via
The Motley Fool
Merck & Co Unusual Options Activity
November 16, 2022
Someone with a lot of money to spend has taken a bullish stance on Merck & Co (NYSE:MRK). And retail traders should know. We noticed this today when the big position showed up on publicly available...
Via
Benzinga
FTX Contagion Spreads To Hong Kong Exchange, Microsoft Outlines New Harassment Policies, Netflix Subscribers Can Terminate Freeloading Account Access: Top Stories Wednesday, Nov. 16
November 16, 2022
Benzinga
Via
Benzinga
Is Merck Too Dependent on Keytruda?
November 09, 2022
The company's top-selling drug brought in the most revenue last quarter and was also its fastest-growing product.
Via
The Motley Fool
Will Merck Continue Its Bullish Streak? A Wyckoff Analysis
November 08, 2022
According to the Wyckoff trading method, Merck's price structure is bullish with enough causes built over the years and lack of threatening supply.
Via
Talk Markets
What 7 Analyst Ratings Have To Say About Merck & Co
October 28, 2022
Merck & Co (NYSE:MRK) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says
November 16, 2022
Via
Benzinga
7 Value Stocks to Buy Before They Pop Off
November 15, 2022
Data shows that it's time for investors to abandon the largest Big Tech names and find attractive value stocks to buy.
Via
InvestorPlace
Dow Drops 211 Points As Stocks Struggle For Direction
November 14, 2022
Stocks looked like they were going to extend Friday's impressive wins, but wound up falling lower by the close.
Via
Talk Markets
European Medicines Agency's Advisory Committee Backs Approval Of AstraZeneca's Three Cancer Drugs
November 14, 2022
Via
Benzinga
These 2 Dividend Paying ETFs Have A Track Record For Increasing Payments, Can Help Diversify Against Industry Risk
November 11, 2022
Investing in an exchange-traded fund that invests in large cap dividend stocks can be a great way to secure passive income.
Via
Benzinga
Why Are Healthcare Stocks Down Today?
November 11, 2022
Healthcare stocks are falling after a false tweet from a Twitter account impersonating Eli Lilly. Here's what this news means for investors.
Via
InvestorPlace
This Is What Whales Are Betting On Merck & Co
November 10, 2022
A whale with a lot of money to spend has taken a noticeably bullish stance on Merck & Co. Looking at options history for Merck & Co (NYSE:MRK) we detected 19 strange trades.
Via
Benzinga
SELLAS Life Sciences' GPS Combo Therapy Shows Overall Survival Of 18 Months In Pretreated Ovarian Cancer Patients
November 10, 2022
Via
Benzinga
Biogen, Seagen Name New CEOs — But One Biotech Stock Crumbles
November 10, 2022
Biogen jumped after naming Christopher Viehbacher its CEO. David Epstein will take over at Seagen.
Via
Investor's Business Daily
Buy Bristol-Myers Squibb, Merck, 10-Year Treasury ETF And This Payments Stock: CNBC's 'Final Trades'
November 10, 2022
On CNBC’s “Halftime Report Final Trades,” Jim Lebenthal of Cerity Partners chose Bristol-Myers Squibb Co. (NYSE: BMY) as his final trade.
Via
Benzinga
Stocks Sharply Lower As Political Gridlock Sets In
November 09, 2022
Stocks sold off today, falling victim to the likelihood of a political gridlock in Washington D.C.
Via
Talk Markets
7 No-Brainer Retirement Stocks to Buy for 2023 and Beyond
November 08, 2022
These no-brainer retirement stocks have proven to be amazingly consistent in delivering incredible returns for investors over time.
Via
InvestorPlace
Election Day Is Here: Which Politicians Are Profiting (Or Losing) On Stocks?
November 08, 2022
U.S. voters will spend the majority of Tuesday casting their ballots for the candidates they want to represent them in Congress, which consists of the House of Representatives and the Senate.
Via
Benzinga
These 3 Dividend ETFs Are a Retiree's Best Friend
November 08, 2022
This trio of exchange-traded funds has trounced the S&P 500 this year.
Via
The Motley Fool
Control Of Congress Up For Grabs In Midterms: 12 Stocks To Watch
November 07, 2022
As voters endeavor to select the congressional candidates they believe would best assist the U.S. in navigating through historical issues it is currently facing, investors are wondering what's going to...
Via
Benzinga
A Novel Immunotherapy That Could Bring Hope To Millions Of Sepsis Patients Received MultiCountry Clearance For Expanded Clinical Trial
November 01, 2022
Enlivex Therapeutics Ltd. (NASDAQ: ENLV) announced that Israel, Spain and Greece have cleared amendments to the company’s Phase II trial protocol that will allow the study to enroll more patients.
Via
Benzinga
Got $3,000? Here Are 3 Stocks to Buy and Hold for the Long Term
November 01, 2022
Great companies grow their top and bottom lines, but they also plug into trends rooted in cultural change, consumer convenience, and practicality.
Via
The Motley Fool
Dogs Of The Dow: An Outperforming Strategy In 2022
October 31, 2022
Via
Talk Markets
Can Biotech Stocks Continue Rallying In This Bear Market?
October 31, 2022
Via
Talk Markets
Why Moderna Stock Soared Last Week
October 30, 2022
The biotech's promising drug pipeline could drive further gains for shareholders.
Via
The Motley Fool
Dogs Of The Dow: A Leading Strategy In 2022
October 30, 2022
At that time the Dow Dogs strategy had a positive year-to-date return versus the negative return of the Dow Jones Industrial Average Index and the S&P 500 Index.
Via
Talk Markets
Stock Market Rally Resilient As Apple Bucks Megacap Meltdown: Weekly Review
October 28, 2022
The Dow and S&P 500 moved above a key level while the Nasdaq rose.
Via
Investor's Business Daily
Merck, Impinj, Clearway Energy And This Defense Play Are CNBC's 'Final Trades'
October 28, 2022
On CNBC’s “Halftime Report Final Trades,” Jenny Harrington of Gilman Hill Asset Management said Clearway Energy Inc. (NYSE: CWEN) is a producer of renewable energy and tr
Via
Benzinga
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
69
70
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.